PME Breakfast Symposium (non-CME) - A Triad of Diseases: A Treatment Strategy for Patients With T2D, CVD, and CKD

Sponsored by Novo Nordisk.

Learn more about the connection between type 2 diabetes (T2D) and chronic kidney disease (CKD) and how patients with these conditions are at an increased cardiovascular (CV) risk in a multidisciplinary discussion.
Explore guideline recommendations for T2D patients with CKD, and/or cardiovascular disease (CVD).
Look at the efficacy and safety from a clinical trial that included cardiorenal outcomes.

We will also review important dosing and administration information.